LUTRELEF 3.2 mg, powder and solvent for solution for injection bottle, 10 ml
Active ingredients: Gonadorelin acetate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 10 mlintraveineuse;sous-cutanée
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- LUTRELEF 3,2 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre - 1 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- FERRING (FRANCE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 1986
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61731639CIP73284363CIP133400932843633Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GONADORÉLINE (ACÉTATE DE)poudre | 3,2 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.